C5 and spindle cell hemangioma: Therefore, the aim of this study was to shed more light on this matter and (i) evaluate alterations in the levels of complement activation products (CAP)—C3a, C5a and C5b-9—in patients with chronic SCH and healthy controls as well as (ii) determine whether these alterations are related to the psychopathological manifestation of SCH.